<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Principles of Blood Transfusion</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 33%;"></div>
                        </div>
                       <span class="progress-text">Lecture 1 of 3</span>
                    </div>
                    <a href="histology-blood-transfusion-clinical-applications.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Principles of Blood Transfusion</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <figure>
                    <img src="../assets/images/2025_09_16_4396154ec810ec024266g-01-1.jpg" alt="Title slide for Blood Transfusion lecture by Dr. George Mugenya." class="content-image">
                </figure>

                <!-- START: introduction -->
                <section id="introduction" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Introduction</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Blood transfusion is the process of transferring blood or blood based products from one individual into the circulation system of another person.
                                <ul>
                                    <li>This is referred to as homologous transfusion.</li>
                                    <li>In autologous transfusion the donor and recipient is the same person.</li>
                                </ul>
                            </li>
                            <li>Earlier transfusions used whole blood but current practice uses only deficient blood components separately (component therapy).</li>
                            <li>The history of practice of blood transfusion can be traced as way back as $15^{\text {th }}$ century.</li>
                            <li>It has evolved through a lot of controversies and sometimes ridiculous experiences into a specialized medical science of today; eg.
                                <ul>
                                    <li>Giving blood orally.</li>
                                    <li>Transfusion of animal blood to human.</li>
                                    <li>Transfusion of milk.</li>
                                    <li>Direct transfusion from donor's vein to recipient's vein, etc).</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                    <div class="content-card">
                        <p>Some of the landmarks in the development of modern transfusion science include:</p>
                        <ul>
                            <li>Description of blood circulatory system by Harvey in $17^{\text {th }}$ century.</li>
                            <li>Discovery of ABO blood groups in 1901</li>
                            <li>Discovery of anticoagulants in 1910s (sodium citrate) and refrigeration to prolong blood storage.</li>
                            <li>Soviet Union set up first national blood bank in 1930s.</li>
                            <li>Discovery of Rhesus group system in 1940 as major cause of transfusion reactions.</li>
                            <li>Discovery of Acid-Citrate-Dextrose (ACD) solution in 1940s to help reduce amount of anticoagulant needed to preserve blood.</li>
                            <li>Introduction of plastic bags to replace glass bottles in 1950.</li>
                            <li>Adoption of WHO policy of voluntary blood donation in 1975.</li>
                            <li>Introduction of CPDA-1 anticoagulant in 1979 to increase shelf life to 35 days.</li>
                            <li>Emergence of HIV in 1980s brought up new challenges in management of blood transfusion services.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: introduction -->

                <!-- START: kenyan-policy -->
                <section id="kenyan-policy" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Kenyan Blood Transfusion Policy</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Kenya is a signatory to World Health Assembly Resolution (WHA 28.72) of 1975 and Regional Commonwealth Ministers of Health Resolution of 1989 which requires:
                                <ul>
                                    <li>Each member state to develop a comprehensive, well coordinated blood transfusion service, based on voluntary, non-remunerated blood donation.</li>
                                    <li>Each member state to make provision for safe blood to the people a national priority.</li>
                                </ul>
                            </li>
                            <li>In different countries the mandate to coordinate national blood transfusion services are entrusted to specific organizations, eg. Red Cross, Red Crescent, AABB , etc.</li>
                            <li>In Kenya this mandate has been given to National Blood Transfusion Services (NBTS):
                                <ul>
                                    <li>It is a unit under National Public Health Laboratories Services (NPHLS).</li>
                                </ul>
                            </li>
                        </ul>
                        <p>The GOAL of NBTS is to provide safe blood whenever it is needed, through creating a strong, efficient, and self sustaining national blood transfusion service capable of meeting all the needs of the country.</p>
                        <p>NBTS is managing the blood transfusion program through:</p>
                        <ul>
                            <li>National Blood Transfusion Centre (NBTC), located in Nairobi.</li>
                            <li>Regional Blood Transfusion Centres (RBTC), located in Mombasa, Embu, Nyeri, Nakuru, Eldoret and Kisumu.</li>
                            <li>Satellite Centres-Naivasha, Eldama-Ravine, Kericho, Kisii, etc.</li>
                            <li>Primary Hospital Blood Banks-though being discouraged/phased out.</li>
                        </ul>
                        <p>The STRATEGY of NBTS to fulfill its mandate include the following:</p>
                        <ul>
                            <li>Proper organizational structures of the blood transfusion services.</li>
                            <li>Recruitment of safe blood donors.</li>
                            <li>Screening of units of blood for Transfusion Transmissible Infections (TTIs).</li>
                            <li>Ensuring appropriate clinical use of blood and blood products; eg. issue transfusion guidelines.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: kenyan-policy -->

                <!-- START: donor-recruitment -->
                <section id="donor-recruitment" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Blood Donor Recruitment</span>
                    </h2>
                    <div class="content-card">
                        <p>The following are the different types of blood donors (sources):</p>
                        <ul>
                            <li>Family / replacement donors - donate blood for a specific/ known recipient.</li>
                            <li>Voluntary / unpaid donors-donate blood to be given to whoever needs it.</li>
                            <li>Commercial / paid donors-donate blood in exchange for money or favours.</li>
                            <li>Autologous donors-donate blood for his / her anticipated use / need.</li>
                        </ul>
                        <p>Criteria for qualification as a blood donor are:</p>
                        <ul>
                            <li>Healthy individual: normal BP and Pulse, not on medications, no history of exposure to TTIs.</li>
                            <li>Age: 16 to 65 years.</li>
                            <li>Weight: 50 kg and above (45-50 kg may be allowed in exceptional circumstances).</li>
                            <li>Haemoglobin level: $12.5 \mathrm{~g} / \mathrm{dl}$ and above (for Autologous $10 \mathrm{~g} / \mathrm{dl}$ and above).</li>
                            <li>Donated blood last not less than 3 months ago (in special circumstances 2 months interval may be allowed).</li>
                            <li>Willing to declare his/her health status both present and past.</li>
                        </ul>
                        <p><strong>Safe Donor:</strong> That person who knows that she/he is at a low risk of TTIs and is willing to give blood voluntarily on a regular basis.</p>
                        <h3 class="subsection-heading">Advantages:</h3>
                        <ul>
                            <li>Are not under pressure to give blood therefore are more likely to meet the national criteria for low risk donors.</li>
                            <li>Are willing to donate blood on a regular basis which is important in maintaining adequate supply of blood.</li>
                            <li>Are at low risk of TTIs because they have been educated about the importance of safe blood and are screened each time they attend to give blood.</li>
                            <li>Are more likely to respond to an appeal for blood donation during an emergency because they have already expressed commitment to voluntary blood donation.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: donor-recruitment -->

                <!-- START: collection-processing-storage -->
                <section id="collection-processing-storage" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Blood Collection, Processing and Storage</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Methods of blood donations are:</h3>
                        <ul>
                            <li>Whole blood donation (commonest):
                                <ul>
                                    <li>All blood components are collected together.</li>
                                </ul>
                            </li>
                            <li>Apheresis donation:
                                <ul>
                                    <li>Only required component(s) is/are donated /collected.</li>
                                    <li>Uncommon and requires expensive equipment.</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Blood Collection</h3>
                        <ul>
                            <li>Donor is screened to ensure normal criteria set for low risk donors is met:
                                <ul>
                                    <li>verbal interview.</li>
                                    <li>through questionnaire.</li>
                                </ul>
                            </li>
                            <li>After disinfecting the skin:
                                <ul>
                                    <li>wide bore needle (G.18) is inserted into a forearm vein.</li>
                                    <li>blood is collected by gravity through the connecting tubing into a plastic bag containing anticoagulant.</li>
                                </ul>
                            </li>
                            <li>Commonly used anticoagulant:
                                <ul>
                                    <li>CPDA-1 (Citrate Phosphate Dextrose with Adenine).</li>
                                    <li>Previously it was ACD and CPD (Acid Citrate Dextrose & Citrate Phosphate Dextrose).</li>
                                </ul>
                            </li>
                            <li>CPDA-1 preserves blood for 35 days while ACD and CPD do it for 21 days.</li>
                            <li>When SAGM (Sodium Adenine Glucose Mannitol) solution is added to CPDA-1 blood can be preserved for up to 42 days.</li>
                        </ul>
                         <h4 class="subsubsection-heading">Actions of ingredients of anticoagulant solutions:</h4>
                         <ul>
                            <li><strong>Citrate:</strong> Prevents coagulation by chelating calcium.</li>
                            <li><strong>Dextrose:</strong> Supports ATP generation by glycolytic pathway.</li>
                            <li><strong>Sodium di-phosphate:</strong> Prevents fall in pH.</li>
                            <li><strong>Adenine:</strong> Synthesizes ATP, increases level of ATP, and extends the shelf life of red blood cells to 35 days.</li>
                        </ul>
                        <ul>
                            <li>Each donation is 450 mls to 500 mls.
                                <ul>
                                    <li>Half filled bags are normally discarded.</li>
                                </ul>
                            </li>
                            <li>The donated blood is immediately placed in a transport box which is maintained at a temperature of +20 to +24 degrees Celsius for not more than 6 to 12 hours.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: collection-processing-storage -->

                <!-- START: blood-processing -->
                <section id="blood-processing" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Blood Processing</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Testing /laboratory screening for TTI:</h3>
                        <ul>
                            <li>HIV (1 & 2)</li>
                            <li>Hepatitis B virus (HBV)</li>
                            <li>Hepatitis C virus (HCV)</li>
                            <li>VDRL for Treponema pallidum (Syphilis)</li>
                            <li>Others: Malaria, Chaga's disease (T. cruzi), Leishmaniasis, CMV (Cytomegalovirus)</li>
                        </ul>
                        <h3 class="subsection-heading">Blood Grouping:</h3>
                        <ul>
                            <li>ABO</li>
                            <li>Rhesus</li>
                        </ul>
                        <h3 class="subsection-heading">Separation of Whole Blood (Hct 40%) into blood components:</h3>
                        <ul>
                            <li><strong>Packed Red Blood Cells (PRBC):</strong>
                                <ul>
                                    <li>250 mls adult packs (Hct 70%).</li>
                                    <li>125 mls paediatric packs (Hct 70%).</li>
                                </ul>
                            </li>
                            <li><strong>Platelets:</strong> 50 mls packs.</li>
                            <li><strong>Fresh Frozen Plasma (FFP):</strong>
                                <ul>
                                    <li>220 mls; contains all coagulation factors.</li>
                                </ul>
                            </li>
                            <li><strong>Cryoprecipitate:</strong>
                                <ul>
                                    <li>15mls; has fibrinogen, factor VIII, XIII and von Willebrand.</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: blood-processing -->

                <!-- START: blood-storage -->
                <section id="blood-storage" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Blood Storage</span>
                    </h2>
                    <div class="content-card">
                        <p>Whole blood and blood components are required to be maintained at specific temperatures (cold chain) for them to be useful when transfused.</p>
                        <ul>
                            <li><strong>Whole blood:</strong> Stored at +2 to +8 deg. C:
                                <ul>
                                    <li>Up to 21 days in ACD or CPD.</li>
                                    <li>Up to 35 days in CPDA-1.</li>
                                    <li>Up to 42 days when SAGM is added to CPDA-1.</li>
                                </ul>
                            </li>
                            <li><strong>Packed Red Blood Cell:</strong> +2 to +8 deg. C and duration as for whole blood.</li>
                            <li><strong>Plasma:</strong>
                                <ul>
                                    <li>+2 to +8 deg. C for up to 5 days.</li>
                                    <li>minus-18 deg. C or below for up to 5 years.</li>
                                </ul>
                            </li>
                            <li><strong>Fresh Frozen Plasma:</strong> minus-18 deg. C or below for up to 1 year.</li>
                            <li><strong>Platelets Concentrate:</strong> Room Temp. with agitation for up to 5 days.</li>
                            <li><strong>Cryoprecipitate:</strong> minus-18 deg. C for up to 1 year.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: blood-storage -->

                <!-- START: autologous-donation -->
                <section id="autologous-donation" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Autologous Blood Donation</span>
                    </h2>
                    <div class="content-card">
                        <p>Donation can be done as whole blood or by apheresis in one of the following ways:</p>
                        <ul>
                            <li><strong>Pre-operative:</strong> Blood is drawn before a planned surgery and stored until needed.</li>
                            <li><strong>Intra-operative haemodilution:</strong> Blood is collected at the start of surgery and then infused during or at the end of the procedure.</li>
                            <li><strong>Blood salvage:</strong> Blood is salvaged from the surgical field and infused during or after the surgical procedure.</li>
                        </ul>
                        <h3 class="subsection-heading">Advantages of Autologous blood donation:</h3>
                        <ul>
                            <li>Prevents transmission of TTIs.</li>
                            <li>Prevents blood transfusion reactions.</li>
                            <li>Provide reassurance to donor-recipient.</li>
                            <li>To stockpile rare blood groups.</li>
                        </ul>
                        <h3 class="subsection-heading">Disadvantages of Autologous blood donation:</h3>
                        <ul>
                            <li>Adverse reaction to donation.</li>
                            <li>Unnecessary loss of blood units if operation is postponed or transfusion is not needed.</li>
                            <li>Increased work load to blood bank: ie needs special labeling and storage facilities.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: autologous-donation -->

                <!-- START: the-future -->
                <section id="the-future" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">The Future</span>
                    </h2>
                    <div class="content-card">
                        <p>Due to increased demand for blood which outstrips the supply:</p>
                        <ul>
                            <li><strong>Blood Substitutes</strong> (artificial blood or blood surrogates) are being developed.
                                <ul>
                                    <li>Being used to fill fluid volume and/or carry oxygen and other blood gases in the cardiovascular system.</li>
                                    <li>The preferred and more accurate terms are: Volume expanders for inert products, and Oxygen therapeutics for oxygen carrying products.</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Volume expanders:</h3>
                        <ul>
                            <li>Inert and merely increase blood volume.
                                <ul>
                                    <li><strong>Crystalloids:</strong> eg. Ringer's lactate, normal saline, D5W</li>
                                    <li><strong>Colloids:</strong> eg. Haemacel, Dextran, Voluven, Gelofusin.</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Oxygen therapeutics:</h3>
                        <ul>
                            <li>Mimic human blood's oxygen transport ability.
                                <ul>
                                    <li><strong>Perfluorocarbon based:</strong> eg. Oxygent, Oxycyte, Perftoran, etc.</li>
                                    <li><strong>Haemoglobin based:</strong> eg. Hemopure, Oxyglobin, PolyHeme, Dextran-Haemoglobin, etc.</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Stem Cell:</h3>
                        <ul>
                            <li>Recently the scientific community has begun to look at the possibility of using stem cells as a means of producing an alternative source of transfusable blood.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: the-future -->

                <!-- START: special-concern -->
                <section id="special-concern" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Special Concern</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Jehovah's Witnesses cannot accept donor packed red cells, platelets, white cells or plasma, and cannot accept autologous or cell-cycled intraoperative transfusion.</li>
                            <li>The sect leadership used to be militantly anti-immunization, anti-germ theory, and anti transplantation as well.</li>
                        </ul>
                         <figure>
                            <img src="../assets/images/2025_09_16_4396154ec810ec024266g-28-1.jpg" alt="A thank you slide, concluding the presentation." class="content-image" style="max-width: 530px;">
                        </figure>
                    </div>
                </section>
                <!-- END: special-concern -->

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="#" class="nav-button disabled">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 33%;"></div>
                        </div>
                       <span class="progress-text">Lecture 1 of 3</span>
                    </div>
                    <a href="histology-blood-transfusion-clinical-applications.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>